The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?

International Journal of Molecular Sciences
Jiji V D AttiaDaniëlle Krijgsman

Abstract

Human leukocyte antigen G (HLA-G) mediates maternal-fetal immune tolerance. It is also considered an immune checkpoint in cancer since it may mediate immune evasion and thus promote tumor growth. HLA-G is, therefore, a potential target for immunotherapy. However, existing monoclonal antibodies directed against HLA-G lack sufficient specificity and are not suitable for immune checkpoint inhibition in a clinical setting. For this reason, it is essential that alternative approaches are explored to block the interaction between HLA-G and its receptors. In this review, we discuss the structure and peptide presentation of HLA-G, and its interaction with the receptors Ig-like transcript (ILT) 2, ILT4, and Killer cell immunoglobulin-like receptor 2DL4 (KIR2DL4). Based on our findings, we propose three alternative strategies to block the interaction between HLA-G and its receptors in cancer immunotherapy: (1) prevention of HLA-G dimerization, (2) targeting the peptide-binding groove of HLA-G, and (3) targeting the HLA-G receptors. These strategies should be an important focus of future studies that aim to develop immune checkpoint inhibitors to block the interaction between HLA-G and its receptors for the treatment of cancer.

References

May 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·A Ishitani, D E Geraghty
Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·A BensussanJ Dausset
Mar 1, 1996·Current Biology : CB·M DiehlH G Rammensee
Apr 6, 1999·The Journal of Experimental Medicine·S Rajagopalan, E O Long
May 4, 1999·International Journal of Cancer. Journal International Du Cancer·L M RealF Garrido
Oct 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·R R LatekE R Unanue
Apr 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·B RiteauE D Carosella
May 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sei-ichi YusaKerry S Campbell
Jun 11, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mathias Faure, Eric O Long
Nov 21, 2002·Cellular and Molecular Life Sciences : CMLS·P MoreauE D Carosella
Nov 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jonathan E BoysonJack L Strominger
Feb 13, 2003·The Journal of Biological Chemistry·Boyoun Park, Kwangseog Ahn
Jul 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Mitsunori ShiroishiKatsumi Maenaka
Jul 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Akiko IshitaniDaniel E Geraghty
Aug 7, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jodie P GoodridgeHilary S Warren
Sep 17, 2003·Tissue Antigens·J LeMaoultE D Carosella
Nov 7, 2003·Human Immunology·Tsufit Gonen-GrossOfer Mandelboim
Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Pedro J MoralesJoan S Hunt
Apr 23, 2004·Proceedings of the National Academy of Sciences of the United States of America·Joël LeMaoultEdgardo D Carosella
Jun 24, 2004·American Journal of Reproductive Immunology : AJRI·Tobias WengenmayerUdo R Markert
Jan 27, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Joël LeMaoultEdgardo D Carosella
Feb 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Craig S ClementsJames McCluskey
Mar 17, 2005·European Journal of Immunology·Vladimir RistichAnatolij Horuzsko
Dec 7, 2005·Molecular Human Reproduction·I L Sargent
Feb 4, 2006·The Journal of Biological Chemistry·Mitsunori ShiroishiKatsumi Maenaka
Oct 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Mitsunori ShiroishiKatsumi Maenaka
Apr 3, 2007·Human Immunology·Craig S ClementsJamie Rossjohn
Sep 12, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A LinM-Y Zhou
May 1, 2008·European Journal of Immunology·Andreas O WeinzierlStefan Stevanović
Jun 10, 2008·Trends in Immunology·Richard AppsAshley Moffett
Jun 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Siyuan LiangAnatolij Horuzsko

❮ Previous
Next ❯

Citations

Jun 1, 2021·Frontiers in Immunology·Qiong-Yuan ChenAifen Lin
Jul 20, 2021·Frontiers in Immunology·Aifen Lin, Wei-Hua Yan
Aug 8, 2021·International Journal of Molecular Sciences·Ricky B van de WaterPeter J K Kuppen

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

Related Papers

International Journal of Molecular Sciences
Daniëlle KrijgsmanPeter J K Kuppen
Seminars in Cancer Biology
Edgardo D Carosella, A Horuzsko
Cellular and Molecular Life Sciences : CMLS
L AmiotBarbara Seliger
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Saadyeh RashidiAsadollah Mohammadi
© 2021 Meta ULC. All rights reserved